Clinical Trial Update: Facilitation of Extinction Retention and Reconsolidation Blockade by IV Allopregnanolone in PTSD. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Massachusetts General Hospital is evaluating intravenous allopregnanolone for facilitating extinction retention and reconsolidation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Allopregnanolone (allopregnanolone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Post Traumatic Stress Disorder | Phase 2 | Status: RECRUITING